Quality control is key

We hold key industry accreditations so that you can be assured that our results are accurate, reliable and consistent

Quality control is key

Expert people

Our team of expert pathologists and trained scientists provides a unique breadth of scientific and diagnostics experience

Expert people

At the heart of science – your trusted diagnostics partner

We work with scientists from pharmaceutical, biotech, CRO, companion diagnostics and healthcare industries

At the heart of science – your trusted diagnostics partner

Cutting edge innovation

We offer a range of services from traditional histopathology techniques to advanced digital pathology, whole slide scanning and development of image analysis algorithms

Cutting edge innovation

Transforming pathology into an objective science

We offer a range of services from traditional histopathology techniques to advanced digital pathology, whole slide scanning and development of image analysis algorithms

Transforming pathology into an objective science

Distinctive strengths

We pride ourselves in understanding your project needs by providing high-quality, consistent and reliable results on time, enabling you to make informed data-driven decisions

Distinctive strengths

Pathology Diagnostics Ltd – a key component of your drug and biomarker development team

We specialise in the provision of clinical diagnostics and quantitative image analysis on human tissues for studies ranging from early discovery to clinical trials

Pathology Diagnostics Ltd – a key component of your drug and biomarker development team

Pathology Diagnostics Ltd. based in Cambridge, UK is an award-winning GCLP  accredited histopathology contract research organisation providing tissue laboratory and diagnostic services to international pharmaceutical, biotechnology and companion diagnostics clients.

We benefit our clients by providing high quality tissue biomarker data for efficacy studies to progress their pipeline candidates and support their out-licensing needs. We have a proven track record in early discovery & preclinical studies, clinical trials, biomarker and companion diagnostic R&D enabling our clients to make objective data driven decisions on their studies.

Our clients benefit from our full range of services from tissue sourcing to digital pathology & quantitative biomarker analysis. We have validated several hundred biomarker assays are leading experts in immune cell analysis for clients with immunotherapy pipelines; as well as experts in digital pathology & image analysis. Our clients also benefit from assurance of the accuracy, consistency and reliability of our data due to our industry quality accreditations.

PDL has a proven track record in all stages of R&D and has also delivered high value studies as partners/lead coordinators in UK national and international grant-funded programmes for product development of biomarkers and companion diagnostics.

We have strong research credentials as an SME in EU grant funded programmes as follows:

  • Partner and coordinator in UK national and EU funded programmes (FP7)
  • Registered with EU as an SME for current EU funded programmes
  • Over 70% of our scientists have higher research degrees
  • Successful delivery of biomarker project in preclinical and clinical samples plus training of  visiting scientists in consortia
  • Multiple publications in peer-reviewed scientific journals; including Clinical Cancer Research, Science and Nature Medicine

At Pathology Diagnostics Ltd we realise that our clients’ satisfaction is paramount. A selection of real feedback from our clients:

It has been a pleasure to work with Pathology Diagnostics Ltd. and very rewarding because of your high competence. Thank you very much!

If you would like further information, please contact us.

Latest Blog

Feb
2015

February 2015: Highlights of the 10th Annual Biomarkers Congress, Manchester, UK: latest pharma industry news

more >

Latest News

Jul
2015

NATURE Publication: Breakthrough Development in Cancer Diagnostics: new in vivo biomarker linked fluorescent probes for fluorescent colonoscopy

more >

Apr
2015

Pathology Diagnostics Ltd. presents at Cambridge business seminar on Managing Change

more >

Events

23 Jun
2015

Dublin Pathology 2015 Dublin Ireland

more >

Publications

July
2015

Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met July 2015 Nature Medicine (2015) doi:10.1038/nm.3641

more >

#3D printing news: US #FDA has approved world's first 3D-printed pill Spritam by Aprecia Pharmaceuticals http://t.co/BLgsmH0WDM

#clinicaltrial news: Merck VSV-EBOV vaccine is 100% effective in Guinea trial says #WHO http://t.co/iSiSPBN8RS

#UK #health news: Scientific Advisory Committee on Nutrition advises entire UK population to take vitamin D pills http://t.co/aLsyTh6bQA

#biomarker #research news: Scientists develop a simple urine test to detect early pancreatic cancer http://t.co/HCWT9534Zz

#UK #research news: #prostate #cancer is five diseases; hope for new treatments http://t.co/5tGdGNLWSU